Current Role of Therapy with Amphotericin B

Systemic antifungal chemotherapy frequently is more difficult to conduct than antibacterial therapy

Richard D. Meyer

2011

Scholarcy highlights

  • Systemic antifungal chemotherapy frequently is more difficult to conduct than antibacterial therapy
  • Amphotericin B has been available for intravenous administration for >30 years and, despite its shortcomings, remains the drug of choice or reference agent in the therapy for many specific systemic fungal infections in various clinical settings
  • Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile

Need more features? Save interactive summary cards to your Scholarcy Library.